C07C 311/14
Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of
Official title: Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
C07C311/14 (Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of) appears on 125 US grants and 130 published applications in this corpus.
Search patents in C07C- Granted patents
- 125
- Published applications
- 130
- Assignees
- 89
- Inventors
- 438
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 0 |
| 2002 | 8 | 2 |
| 2003 | 4 | 5 |
| 2004 | 3 | 9 |
| 2005 | 3 | 2 |
| 2006 | 5 | 3 |
| 2007 | 3 | 3 |
| 2008 | 2 | 2 |
| 2009 | 3 | 10 |
| 2010 | 7 | 7 |
| 2011 | 4 | 6 |
| 2012 | 3 | 10 |
| 2013 | 4 | 7 |
| 2014 | 9 | 8 |
| 2015 | 10 | 3 |
| 2016 | 4 | 3 |
| 2017 | 2 | 6 |
| 2018 | 4 | 4 |
| 2019 | 3 | 3 |
| 2020 | 3 | 3 |
| 2021 | 5 | 6 |
| 2022 | 2 | 8 |
| 2023 | 0 | 4 |
| 2024 | 4 | 6 |
| 2025 | 6 | 5 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Inhibitors of phospholipid synthesis and methods of use3 Feb 2026US 12,540,115 B2The Board of Trustees of the Leland Stanford Junior University
- Phenylalanine-based LAT1 inhibitors and uses thereof30 Sep 2025US 12,427,124 B1Maxymune Therapeutics, Inc.
- Modulators of sestrin-GATOR2 interaction and uses thereof5 Aug 2025US 12,378,263 B2Navitor Pharmaceuticals, Inc.
- Disubstituted alkyne derivatives8 Jul 2025US 12,351,570 B2Merck Patent GmbH
- Kcnt1 inhibitors comprising a phenyl, pyridine, or pyrimidine core and methods of use16 Jul 2026US 2026/0199311 A1Praxis Precision Medicines, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Dihydroindene derivatives as malt1 inhibitors2 Jul 2026US 2026/0184687 A1C4X Discovery Limited
- Modulators of sestrin-gator2 interaction and uses thereof26 Feb 2026US 2026/0055122 A1Navitor Pharmaceuticals, Inc.
- Papd5 inhibitors, pharmaceutical compositions, and methods of treating neurological and cognitive disorders12 Feb 2026US 2026/0041655 A1Miralogx LLC
Most cited
By later US patents
- IL-8 receptor antagonists84US 6,005,008 ASmithKline Beecham Corporation · 1999
- Npyy5 antagonists74US 6,699,891 B1Shionogi & Co., Ltd. · 2004
- α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors56US 6,248,775 B1G. D. Searle & Co. · 2001
- Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient54US 6,448,290 B1Ono Pharmaceutical Co., Ltd. · 2002
- .alpha.-and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors43US 5,843,946 AG. D. Searle & Co. · 1998